Spanish pharmaceutical company Grifols is planning to take advantage of balmy market conditions with a refinancing package that will replace most of its outstanding debt. The package will consist of a $3bn term loan B in dollars, a $1.6bn TLB in euros and $1.25bn of senior secured bonds issued in euros.
The TLBs will have a tenor of eight years. The roadshow for the bond will be launched later.
With the new loans and notes, Grifols wants to reduce the cost of debt, increase maturities and improve flexibility in terms, the company said in a statement